Overview
Jean-christophe Thalabard practices practicing medicine in Paris, France.
His clinical expertise encompasses Anal Cancer, Breast Cancer, and Endometrial Cancer.
He is actively involved in clinical research, co-authoring 26 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jean-christophe C. Thalabard
Is Jean-christophe C. Thalabard a top-rated expert for Anal Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Jean-christophe C. Thalabard is classified as an Experienced expert for Anal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jean-christophe C. Thalabard participate in research or clinical trials?
Yes. Jean-christophe C. Thalabard has published 26 articles and abstracts on conditions like Anal Cancer. You can view a list of Jean-christophe C. Thalabard's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Anal CancerMr. Thalabard isExperienced. Learn about Anal Cancer.
- Breast CancerMr. Thalabard isExperienced. Learn about Breast Cancer.
- Endometrial CancerMr. Thalabard isExperienced. Learn about Endometrial Cancer.